Compare Stocks → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison TSE:ANXNASDAQ:ECXNYSE:NTGCNSX:VP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANXAnaconda MiningC$0.51C$0.46▼C$1.05C$92.37MN/A122,595 shs21,993 shsECXECARX$1.96+0.5%$2.43$1.87▼$9.34$73.50M0.294,942 shs257,502 shsNTGTortoise Midstream Energy Fund$38.37+1.9%$35.79$31.25▼$38.38N/AN/A14,113 shs15,599 shsVPVodis Pharmaceuticals$0.00$0.16▼$0.62N/AN/A1,714 shs51,582 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANXAnaconda Mining0.00%0.00%0.00%0.00%0.00%ECXECARX+1.56%-4.88%-30.85%-32.53%-62.79%NTGTortoise Midstream Energy Fund+0.94%+0.40%+6.15%+7.63%+17.55%VPVodis Pharmaceuticals0.00%0.00%0.00%0.00%0.00%Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANXAnaconda MiningN/AN/AN/AN/AN/AN/AN/AN/AECXECARX1.5509 of 5 stars3.52.00.00.03.30.80.0NTGTortoise Midstream Energy Fund0.3624 of 5 stars0.04.00.00.02.11.70.0VPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANXAnaconda MiningN/AN/AN/AN/AECXECARX3.00Buy$10.00410.20% UpsideNTGTortoise Midstream Energy FundN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANXAnaconda MiningC$27.80M0.00N/A8.84C$0.39 per share0.00ECXECARX$657.10M0.11N/AN/A($3.13) per share-0.63NTGTortoise Midstream Energy Fund$9.46MN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANXAnaconda MiningN/A-C$0.04N/AN/AN/AN/AN/AN/AN/AECXECARX-$132.60M-$0.38N/A∞N/A-20.03%N/A-23.13%6/10/2024 (Estimated)NTGTortoise Midstream Energy FundN/A-$0.03N/A∞N/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest REDD, VP, NTG, ANX, and ECX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/28/2024Q4 2023ECXECARXN/A-$0.12-$0.12-$0.12N/A$263.10 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANXAnaconda MiningN/AN/AN/AN/AN/AECXECARXN/AN/AN/AN/AN/ANTGTortoise Midstream Energy Fund$3.088.03%+1.22%N/A N/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/ALatest REDD, VP, NTG, ANX, and ECX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/7/2024NTGTortoise Midstream Energy Fundquarterly$0.779%2/21/20242/22/20242/29/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANXAnaconda Mining2.261.090.69ECXECARXN/A0.780.74NTGTortoise Midstream Energy FundN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipANXAnaconda MiningN/AECXECARXN/ANTGTortoise Midstream Energy FundN/AVPVodis PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipANXAnaconda MiningN/AECXECARX20.00%NTGTortoise Midstream Energy FundN/AVPVodis PharmaceuticalsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableANXAnaconda Mining93181.12 millionN/ANot OptionableECXECARX1,50137.50 million30.00 millionNot OptionableNTGTortoise Midstream Energy FundN/AN/AN/ANot OptionableVPVodis PharmaceuticalsN/AN/AN/ANot OptionableREDD, VP, NTG, ANX, and ECX HeadlinesSourceHeadlineCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™tmcnet.com - March 27 at 1:27 PMStates' drug pricing boards off to a slow startmsn.com - March 22 at 8:16 AMGLP-1s set to take drug sales throne from PD-1 inhibitors in 2024mmm-online.com - March 20 at 6:45 PMVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Callmsn.com - February 25 at 2:28 PMAbivax appoints Ana Sharma as Vice President, Global Head of Qualitymarkets.businessinsider.com - February 7 at 8:56 AMMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Healthmarkets.businessinsider.com - January 24 at 1:10 PMSenior Vice Presidentgovtech.com - December 20 at 9:06 AMDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023msn.com - December 14 at 3:30 PMBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsmsn.com - December 7 at 3:45 PMThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsabcnews.go.com - December 7 at 9:38 AMAmneal Pharma in pact with Strides to launch generic Vascepamsn.com - December 1 at 3:25 PMAnavex Life Sciences Appoints Senior VP of Regulatory Affairsmarkets.businessinsider.com - November 6 at 8:21 AMXpeng's vice president suspended amid corruption investigation in supply chain managementfoxnews.com - October 14 at 11:38 PMLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drugmarketwatch.com - October 9 at 6:33 PMStrengthening of vertical integration: Exyte completes acquisition of pure media specialist Integamarkets.businessinsider.com - October 4 at 6:44 AMVice Presidentnewsweek.com - September 19 at 1:02 PMRepublican voters want Donald Trump. And his vice president? How about more Trump?usatoday.com - August 28 at 4:23 AMTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesnews.yahoo.com - August 22 at 4:12 AMVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcriptmsn.com - August 1 at 10:03 PMSee which pharma brands are the strongest and fastest-growing in 2023mmm-online.com - July 12 at 1:54 PMSenior Vice President, Corporate Development and Global Strategywebmd.com - June 9 at 11:51 PMWhat has Kamala Harris done as vice president?news.yahoo.com - May 29 at 8:36 AMAHIP Marketing Campaign Targets Pharma’s Prescription Drug Pricinghealthpayerintelligence.com - April 24 at 7:41 PMMeet our President and Vice Chancellorlse.ac.uk - April 9 at 10:43 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Ways5 Under-the-Radar Artificial Intelligence (AI) Stocks March 4, 2024 9:30 AMView 5 Under-the-Radar Artificial Intelligence (AI) Stocks Reddit IPO: Analyzing Upvotes, Downvotes, and Financial PotentialMarch 12, 2024 7:43 AMView Reddit IPO: Analyzing Upvotes, Downvotes, and Financial PotentialDoes Reddit's Successful Public Debut Mean Tech IPOs are Back?March 22, 2024 6:15 AMView Does Reddit's Successful Public Debut Mean Tech IPOs are Back?2 Cannabis Stocks Clawing Back from the Grave, Germany LegalizesMarch 25, 2024 7:00 AMView 2 Cannabis Stocks Clawing Back from the Grave, Germany LegalizesAll Headlines Company DescriptionsAnaconda MiningTSE:ANXAnaconda Mining Inc. operates as a gold mining, development, and exploration company in Canada. It holds a 100% interest in the Point Rousse project comprising 6 mining leases and 7 mineral licenses with a total of 5,552 hectares located in the Baie Verte Mining District, Newfoundland; and the Goldboro Gold project comprising 37 contiguous claims covering an area of 592 hectares situated to the northeast of Halifax, Nova Scotia. The company also holds a 100% interest in the Tilt Cove property that covers an area of approximately 11,000 hectares located within the Baie Verte Mining District. Anaconda Mining Inc. was incorporated in 1994 is headquartered in Toronto, Canada.ECARXNASDAQ:ECXECARX Holdings Inc. develops a full stack automotive computing platform to reshape the mobility market worldwide. Its principal products include infotainment head units, digital cockpits, and vehicle chip-set solutions, as well as core operating system and integrated software stack. The company was founded in 2017 and is based in London, the United Kingdom.Tortoise Midstream Energy FundNYSE:NTGTortoise MLP Fund, Inc. is a close ended equity mutual fund launched and managed by Tortoise Capital Advisors L.L.C. It invests in public equity markets. The fund primarily invests in equity securities of MLPs and their affiliates, with an emphasis on natural gas infrastructure Master Limited Partnerships. It employs a fundamental analysis with a bottom up stock picking approach with focus on factors like quantitative, qualitative, and relative value factors to create its portfolio. Tortoise MLP Fund, Inc. was formed on July 27, 2010 is domiciled in United States.Vodis PharmaceuticalsCNSX:VPVodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.